Cargando…
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
BACKGROUND: Fetal smallness affects 10% of pregnancies. Small fetuses are at a higher risk of adverse outcomes. Their management using estimated fetal weight and feto-maternal Doppler has a high sensitivity for adverse outcomes; however, more than 60% of fetuses are electively delivered at 37 to 38...
Ejemplares similares
-
Transplantation of Human-Fetal-Spinal-Cord-Derived NPCs Primed with a Polyglutamate-Conjugated Rho/Rock Inhibitor in Acute Spinal Cord Injury
por: Giraldo, Esther, et al.
Publicado: (2022) -
Shared risk factors for COVID‐19 and preeclampsia in the first trimester: An observational study
por: Serrano, Berta, et al.
Publicado: (2022) -
Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor
por: Garcia‐Manau, Pablo, et al.
Publicado: (2023) -
Feto-maternal microchimerism: Memories from pregnancy
por: Cómitre-Mariano, Blanca, et al.
Publicado: (2021) -
Bisphenol a Interferes with Uterine Artery Features and Impairs Rat Feto-Placental Growth
por: Barberio, Laura, et al.
Publicado: (2021)